Investors aiming to benefit from large price gains frequently use a mix of technical and fundamental analysis. One tactic is to filter for stocks showing solid core business expansion, marked by increasing revenues and earnings, while also presenting favorable technical formations that indicate a possible move out of a period of sideways trading. This technique tries to find firms where better core business performance might be ready to start a new upward stage in the share price. A recent filter for "Strong Growth Stocks with good Technical Setup Ratings" has identified PACS Group Inc (NYSE:PACS) as a stock deserving further examination.

PACS Group Inc is a holding company centered on the post-acute healthcare field, running a collection of skilled nursing and senior living facilities in 17 states. The company began public trading in April 2024 and offers a range of technology and support services to its independently run facilities, caring for more than 31,000 patients each day.
Fundamental Growth Evaluation
The basis of this filtering tactic is finding solid business expansion, as continued earnings and sales growth are main forces behind long-term share performance. According to the fundamental analysis report for PACS, the company gets a 7 out of 10 in the Growth rating, which is the most positive part of its total fundamental picture. The report points out several important measures:
- Revenue Growth: The company displays very good top-line increase, with revenue rising 29.32% over the last year and averaging 29.74% growth over recent years.
- Earnings Per Share (EPS) Growth: On the bottom line, PACS shows notable speed, with EPS jumping 64.52% in the past year.
- Future Expectations: Analysts believe this growth path will persist, with predicted yearly EPS growth of 11.63% in the next years. The report states that the EPS growth rate is increasing, meaning future growth is estimated to be faster than the historical average.
This growth picture is important because, as described in the framework of growth investing, investors look for companies predicted to grow faster than their competitors and the market. PACS’s good revenue and earnings increase within the necessary healthcare services field indicates it is gaining market position and enlarging its operations successfully.
Valuation and Financial Condition Background
While growth is key, the filtering system also calls for acceptable profitability and financial condition to confirm the company is on a stable course. PACS’s total fundamental rating is a neutral 5 out of 10, with varied signs across other groups.
- Valuation (Rating: 5/10): The stock seems fairly valued compared to its industry. Its Price/Earnings ratio of 18.62 is lower than 73% of its peers in the Health Care Providers & Services industry and is also under the current S&P 500 average.
- Profitability (Rating: 6/10): The company is regularly profitable with positive cash flow. It has a good Return on Equity of 20.23%, doing better than 88% of industry peers, although other margin measures have experienced some recent strain.
- Financial Health (Rating: 5/10): The balance sheet shows an acceptable debt-to-equity ratio of 0.50 and a very good debt-to-free-cash-flow ratio, pointing to acceptable solvency. However, liquidity measures like the Current Ratio are only satisfactory.
For a growth stock, these ratings are tolerable. The attention stays on the growth path, while the valuation is not high and the financial base shows no clear warning signs, matching the "decent" condition and profitability filter of the screen.
Technical Formation and Breakout Possibility
The second part of this tactic concerns timing, using technical study to find a possible entry point as the stock gathers force for a new advance. The technical analysis report for PACS gives a solid Setup Rating of 7 out of 10, signaling a positive pattern.
- Trend and Consolidation: Both the long-term and short-term trends for PACS are positive. The stock has done much better than the market over the past year. Lately, it has been trading in a sideways range between about $29.36 and $36.66, which is a typical formation before a clear breakout.
- Key Resistance and Support: The report finds a clear resistance area between $35.21 and $35.98, made by a mix of trend lines and moving averages. A maintained move above this area could show the start of a new upward stage. On the other hand, strong support exists near the $34.15 level.
- Setup Summary: The technical report states that PACS "presents a nice setup opportunity," mentioning lower volatility during consolidation and attention from large investors. It proposes a breakout above the $35.99 resistance level could act as a possible signal.
This technical background is important for the strategy because it tries to match an investment with a time of building speed. A breakout from consolidation, particularly when paired with good fundamentals, can frequently result in a time of faster price gain as new purchasers come into the market.
Summary
PACS Group Inc presents a situation that fits a growth-and-breakout investment idea. Fundamentally, the company is showing forceful revenue and earnings growth inside the stable healthcare field, trading at a fair valuation relative to its industry. Technically, the stock is in a positive long-term trend and is tightening in a consolidation formation near a set resistance level, indicating a possible breakout may be near. This mix of increasing core business performance and a positive technical formation is exactly what the filtering system tries to find.
For investors curious about examining other stocks that fit similar standards of good growth combined with favorable technical patterns, you can see the full Strong Growth Stock Technical Setups Screen.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, a recommendation, or an offer to buy or sell any securities. Investing involves risk, including the potential loss of principal. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
